Debevoise & Plimpton LLP

Debevoise & Plimpton LLP advises leading life sciences and private equity companies on corporate transactions and complex and large-scale litigation. The practice also counsels on the regulatory aspects of transactions, as well as regulatory compliance and enforcement. The practice is co-chaired by six lawyers, including New York-based Andrew Bab, Jennifer Chu, and Kevin Rinker, all advising on corporate transactions such as M&A and joint ventures, with the latter also working on private equity. Also in New York are Mark Goodman, experienced in civil litigation, white-collar defense, and internal investigations, and Maura Monaghan, who works in criminal investigations, arbitration, and commercial litigation – including product liability and mass tort. On the regulatory side is Paul Rubin, in Washington DC, who counsels on FDA strategy, compliance, and enforcement.